Understand the source comparison
Can Peptides Help Bulging Disc: Dosage Forms & Purity Comparison
BPC-157 250–500mcg twice daily Bacteriostatic water 28 days at 2–8°C Upregulates VEGF, reduces IL-6/TNF-alpha, promotes collagen type I synthesis in annular fibres Most studied for disc injury; stronger evidence base than TB-500 for cartilaginous tissue repair
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- 250–500mcg twice daily
- Bacteriostatic water
- 28 days at 2–8°C
- Upregulates VEGF, reduces IL-6/TNF-alpha, promotes collagen type I synthesis in annular fibres
- Most studied for disc injury; stronger evidence base than TB-500 for cartilaginous tissue repair
- TB-500
- 2–5mg weekly
- 30 days at 2–8°C
- Actin sequestration drives fibroblast migration; enhances angiogenesis at hypoxic injury sites
- Broader soft tissue data; disc-specific evidence limited to extrapolation from tendon studies
- Thymalin
- 5–10mg every 5 days
- 21 days at 2–8°C
- Thymic peptide; immune modulation rather than direct tissue repair. Not primary candidate for disc injury
- Indirect benefit through systemic inflammation reduction; not a first-line choice for localised disc pathology
- Cerebrolysin
- 10–30mL IV over 10 days
- Pre-mixed injectable
- N/A. Use immediately
- Neuroprotective; may reduce nerve inflammation from compression but does not address disc tissue itself
- Used in radiculopathy management; complements but does not replace disc-targeted peptides
- BPC-157 and TB-500 are the only peptides in this comparison with direct evidence for connective tissue repair mechanisms relevant to intervertebral discs. Thymalin and Cerebrolysin address peripheral symptoms (immune dysregulation, nerve inflammation) but lack the growth factor signalling required for annular fibre healing.